IRVINE, Calif.--(BUSINESS WIRE)--As the U.S. Senate considers easing restrictions on embryonic stem cell research and a separate bill that would fund alternatives, PrimeCell™ Therapeutics’ lead stem cell researcher, Francisco Silva, is available to discuss the company’s groundbreaking research in this field.
